203 related articles for article (PubMed ID: 30146180)
41. Closure of patent foramen ovale or medical therapy alone for secondary prevention of cryptogenic cerebrovascular events.
Fortuni F; Crimi G; Leonardi S; Angelini F; Raisaro A; Lanzarini LF; Oltrona Visconti L; Ferrario M; De Ferrari GM
J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):373-381. PubMed ID: 29708911
[TBL] [Abstract][Full Text] [Related]
42. PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: a systematic review and meta-analysis.
Ntaios G; Papavasileiou V; Makaritsis K; Michel P
Int J Cardiol; 2013 Oct; 169(2):101-5. PubMed ID: 24041984
[TBL] [Abstract][Full Text] [Related]
43. Patent Foramen Ovale Closure Versus Medical Therapy for Cryptogenic Ischemic Stroke: A Topical Review.
Saver JL; Mattle HP; Thaler D
Stroke; 2018 Jun; 49(6):1541-1548. PubMed ID: 29760277
[No Abstract] [Full Text] [Related]
44. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
Pickett CA; Villines TC; Ferguson MA; Hulten EA
Am J Cardiol; 2014 Nov; 114(10):1584-9. PubMed ID: 25248812
[TBL] [Abstract][Full Text] [Related]
45. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
46. Patent Foramen Ovale Closure in the Setting of Cryptogenic Stroke: A Meta-Analysis of Five Randomized Trials.
Garg L; Haleem A; Varade S; Sivakumar K; Shah M; Patel B; Agarwal M; Agrawal S; Leary M; Kluck B
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2484-2493. PubMed ID: 29805084
[TBL] [Abstract][Full Text] [Related]
47. Closure versus Medical Therapy for Patent Foramen Ovale in Patients with Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Controlled Trials.
Qiu B; Cai Y; Wang D; Lin J; Fan Y
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3463-3472. PubMed ID: 30185398
[TBL] [Abstract][Full Text] [Related]
48. Long-term experience and outcomes with transcatheter closure of patent foramen ovale.
Inglessis I; Elmariah S; Rengifo-Moreno PA; Margey R; O'Callaghan C; Cruz-Gonzalez I; Baron S; Mehrotra P; Tan TC; Hung J; Demirjian ZN; Buonanno FS; Ning M; Silverman SB; Cubeddu RJ; Pomerantsev E; Schainfeld RM; Dec GW; Palacios IF
JACC Cardiovasc Interv; 2013 Nov; 6(11):1176-83. PubMed ID: 24262618
[TBL] [Abstract][Full Text] [Related]
49. Safety Outcomes After Percutaneous Transcatheter Closure of Patent Foramen Ovale.
Merkler AE; Gialdini G; Yaghi S; Okin PM; Iadecola C; Navi BB; Kamel H
Stroke; 2017 Nov; 48(11):3073-3077. PubMed ID: 28939677
[TBL] [Abstract][Full Text] [Related]
50. Transcatheter Patent Foramen Ovale Closure After Cryptogenic Stroke: An Updated Meta-Analysis of Randomized Trials.
Mojadidi MK; Elgendy AY; Elgendy IY; Mahmoud AN; Elbadawi A; Eshtehardi P; Patel NK; Wayangankar S; Tobis JM; Meier B
JACC Cardiovasc Interv; 2017 Nov; 10(21):2228-2230. PubMed ID: 29122137
[No Abstract] [Full Text] [Related]
51. Prevention of recurrent stroke in patients with patent foramen ovale.
Wessler BS; Kent DM
Neurol Clin; 2015 May; 33(2):491-500. PubMed ID: 25907918
[TBL] [Abstract][Full Text] [Related]
52. Patent foramen ovale.
Dattilo PB; Kim MS; Carroll JD
Cardiol Clin; 2013 Aug; 31(3):401-15. PubMed ID: 23931102
[TBL] [Abstract][Full Text] [Related]
53. Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials.
Pickett CA; Villines TC; Resar JR; Hulten EA
Int J Cardiol; 2018 Dec; 273():74-79. PubMed ID: 30119914
[TBL] [Abstract][Full Text] [Related]
54. Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents: initial experiences in Japan.
Kijima Y; Akagi T; Nakagawa K; Taniguchi M; Ueoka A; Deguchi K; Toh N; Oe H; Kusano K; Sano S; Ito H
Cardiovasc Interv Ther; 2014 Jan; 29(1):11-7. PubMed ID: 23824518
[TBL] [Abstract][Full Text] [Related]
55. Prevention of stroke in patients with patent foramen ovale.
Mattle HP; Meier B; Nedeltchev K
Int J Stroke; 2010 Apr; 5(2):92-102. PubMed ID: 20446943
[TBL] [Abstract][Full Text] [Related]
56. Transcatheter closure of the patent foramen ovale in children: intermediate-term follow-up results.
Sel K; Aykan HH; Duman D; Aypar E; Özkutlu S; Alehan D; Karagöz T
Cardiol Young; 2017 Oct; 27(8):1545-1549. PubMed ID: 28460651
[TBL] [Abstract][Full Text] [Related]
57. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
[TBL] [Abstract][Full Text] [Related]
58. Amplatzer occluder versus CardioSEAL/STARFlex occluder: a meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect.
Li Y; Zhou K; Hua Y; Wang C; Xie L; Fang J; Rong X; Shen J
Cardiol Young; 2013 Aug; 23(4):582-96. PubMed ID: 23199453
[TBL] [Abstract][Full Text] [Related]
59. Stroke prevention by percutaneous closure of patent foramen ovale: a meta-analytic review.
Nagaraja V; Eslick GD
Int J Cardiol; 2014 Mar; 172(2):524-6. PubMed ID: 24485622
[No Abstract] [Full Text] [Related]
60. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
